These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 5468731)

  • 1. [Therapy of ischemic heart diseases with carbochromen].
    Savenkov PM; Arsukuni RO; Pflug C
    Arzneimittelforschung; 1970 Mar; 20():461-2. PubMed ID: 5468731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of coronary insufficiency with carbochromen].
    Kipsidze NN; Capidze GJ
    Arzneimittelforschung; 1970 Mar; 20():456-9. PubMed ID: 4989253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of carbochromen in coronary insufficiency].
    Kobaladze SG; Saginjan VS; Sonija GS; Masasvili LS; Celisvili NV
    Arzneimittelforschung; 1970 Mar; 20():468-9. PubMed ID: 5468734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of carbochromen on the cerebral blood circulation].
    Zarov EI; Martynov AI
    Arzneimittelforschung; 1970 Mar; 20():446-8. PubMed ID: 5468728
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
    Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R; Persić T; Custović F
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Extracoronary" effect of carbochromen on the circulation].
    Votcal BE; Zmurkin VP; Rogunov GA; Trosina TP; Alijeva ZM
    Arzneimittelforschung; 1970 Mar; 20():442-6. PubMed ID: 5468727
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE; Lozinskij LG
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of clinical testing of carbochromen in chronic coronary insufficiency].
    Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA
    Arzneimittelforschung; 1970 Mar; 20():449-51. PubMed ID: 4916579
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the pharmacodynamics of carbochromen].
    Nitz RE
    Arzneimittelforschung; 1970 Mar; 20():433-8. PubMed ID: 4318217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 15. The incidence and relative frequencies of congenital heart disease in school children aged 7 to 16 in Shiga Prefecture.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Ito H
    Jpn Circ J; 1971 Aug; 35(8):903-14. PubMed ID: 5171691
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Promotion of organ circulation by raubasine].
    Dietmann K
    Arzneimittelforschung; 1967 Aug; 17(8):969-75. PubMed ID: 5632071
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of magnesium asparaginate on the coronary circulation.
    Görög P; Ezer E; Szporny L
    Arzneimittelforschung; 1966 Nov; 16(11):1488-90. PubMed ID: 6014963
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of coronary heart disease from the modern point of view].
    Dockweiler J
    Arzneimittelforschung; 1968 Aug; 18(8):1081-4. PubMed ID: 5755842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.